3.65k followers • 20 symbols Watchlist by Motif Investing
Global adoption of minimally invasive procedures could spark new growth. The global minimally invasive surgery market is forecast to reach $35.5 billion by the end of 2016 with compound annual growth rate ("CAGR") of 8.2%.
Intuitive Surgical, Inc.
Boston Scientific Corporation
Smith & Nephew plc
Globus Medical, Inc.
Cardiovascular Systems, Inc.
K2M Group Holdings, Inc.
Mazor Robotics Ltd.
The direction of the NZD/USD on Friday is likely to be determined by trader reaction to the minor 50% level at .6483.
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2020 on Wednesday, July 29, 2020
U.S. companies are expanding and opening new plants in the Dominican Republic as they diversify their supply chains, moves that will help offset the economic impact of the new coronavirus pandemic, the Dominican economy minister said. Juan Ariel Jimenez told Reuters he expected the Caribbean island nation to boost exports by 5 to 10% in 2021, aided in part by a rise in gold prices, as well as increased production of medical devices and equipment, a key growth sector. Two medical equipment makers, Florida-based Jabil and the U.S. unit of Italy's privately-held COSMED, began operations in the Dominican Republic in recent months, said Silvia Cochon of the Dominican National Free Zones Council.
The direction of the NZD/USD the rest of the session on Friday is likely to be determined by trader reaction to the pivot at .6483.
Progress towards a COVID-19 vaccine and positive EU and U.S stats provided support early on. U.S Nonfarm payrolls and jobless claims are in focus later.
There’s plenty to consider as we enter the 3rd quarter. Brexit, a labor market recovery, possible trade wars, and Trump are all there to influence…
In the latest trading session, Medtronic (MDT) closed at $92.32, marking a +0.68% move from the previous day.
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter of 2020 after the market close on Wednesday, July 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
QIAGEN's (QGEN) acquisition deal with Thermo Fisher receives approval from QIAGEN shareholders.
It is hard to get excited after looking at Smith & Nephew's (LON:SN.) recent performance, when its stock has declined...
Calgary, Alberta--(Newsfile Corp. - June 30, 2020) - Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) ("Braveheart" or, the "Company") hereby announces the engagement of GRA Enterprises LLC for the provision of investor relations services pursuant to a consulting agreement dated June 5, 2020. Services include the production and publication of investor relations bulletins, distribution of investor bulletins to the consultant's e-mail list, and posts through the consultant's blogs and social media accounts. ...
This solution by LabCorp (LH) takes the idea from Covance's COVID-19 Operational Recovery Team to better understand the necessities.
The uptick in Bio-Rad's (BIO) core PCR and Droplet Digital PCR product revenues is the result of robust demand due to coronavirus testing and related research.
Zacks.com featured highlights include: Keurig Dr Pepper, Hologic, Meritage Homes, Vistra Energy and Sally Beauty
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2020 on Wednesday, July 29, 2020 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter on Wednesday, July 29, 2020, prior to the conference call.
In New Zealand, business confidence continues to improve as the economy returns to normal but still points to a recession according to an ANZ Survey.
It’s a busy day ahead, with economic data, talk of stimulus, geopolitics, and COVID-19 updates to provide the majors with direction.
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Myriad Genetics' (MYGN) myPath Melanoma's accuracy to classify skin lesions, termed as indeterminate by standard pathological review, validated by the latest study.